DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Relevance of oxidative stress in inhibition of eIF2 alpha phosphorylation and stress granules formation during Usutu virus infection
20 Pág., Usutu virus (USUV) is an African mosquito-borne flavivirus closely related to West Nile, Japanese encephalitis, Zika, and dengue viruses. USUV emerged in 1996 in Europe, where quickly spread across the continent causing a considerable number of bird deaths and varied neurological disorders in humans, including encephalitis, meningoencephalitis, or facial paralysis, thus warning about USUV as a potential health threat. USUV replication takes place on the endoplasmic reticulum (ER) of infected cells, inducing ER stress and resulting in the activation of stress-related cellular pathways collectively known as the integrated stress response (ISR). The alpha subunit of the eukaryotic initiation factor eIF2 (eIF2α), the core factor in this pathway, is phosphorylated by stress activated kinases: protein kinase R (PKR), PKR-like endoplasmic reticulum kinase (PERK), heme-regulated inhibitor kinase (HRI), and general control non-repressed 2 kinase (GCN2). Its phosphorylation results, among others, in the downstream inhibition of translation with accumulation of discrete foci in the cytoplasm termed stress granules (SGs). Our results indicated that USUV infection evades cellular stress response impairing eIF2α phosphorylation and SGs assembly induced by treatment with the HRI activator ArsNa. This protective effect was related with oxidative stress responses in USUV-infected cells. Overall, these results provide new insights into the complex connections between the stress response and flavivirus infection in order to maintain an adequate cellular environment for viral replication., This work was supported by grants RTA2015-009 (J-C. S.) and E-RTA20017-003-C02 (J-C. S.) from INIA, PID2019-105117RR-C21(HOSTMEVIR) (J-C. S.) from the Spanish Ministerio de Ciencia e Innovación, (J-C. S.) from Instituto de Salud Carlos III, and S2018/BAA-4370 (PLATESA-2) (J-C. S.) from the Comunidad Autónoma de Madrid., Peer reviewed
Proyecto:
INIA / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 RTA2015-009
,
INIA E-RTA20017-003-C02
,
AEI PID2019-105117RR-C21
,
Instituto de Salud Carlos III COV20
DOI: http://hdl.handle.net/10261/272372, https://api.elsevier.com/content/abstract/scopus_id/85100215990
HANDLE: http://hdl.handle.net/10261/272372, https://api.elsevier.com/content/abstract/scopus_id/85100215990